Telesis Bio, Inc. TBIO
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -17.08% | 2.49% | 1.54% | 27.75% |
| Total Depreciation and Amortization | -- | 16.73% | 22.65% | 44.70% | 57.03% |
| Total Amortization of Deferred Charges | -- | 72.32% | 49.17% | 58.71% | 63.84% |
| Total Other Non-Cash Items | -- | 301.41% | 231.59% | 268.76% | 47.79% |
| Change in Net Operating Assets | -- | 110.41% | 52.13% | -595.75% | -814.85% |
| Cash from Operations | -- | 61.10% | 39.63% | 10.50% | 27.54% |
| Capital Expenditure | -- | 49.01% | 55.75% | 56.36% | 51.37% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -111.69% | -88.26% | 70.65% | 105.67% |
| Cash from Investing | -- | -112.48% | -92.61% | 68.01% | 97.61% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -0.09% | 0.05% | -0.09% | 99.62% |
| Issuance of Common Stock | -- | -63.19% | -54.86% | -58.62% | -96.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -48.27% | 1,031.78% | 1,031.78% | 185.71% |
| Cash from Financing | -- | -149.17% | 160.62% | 156.43% | 508.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -247.18% | -63.65% | 44.75% | 91.35% |